How HIMS Will Hand Us 1,000%-Plus Gains
I read every subscriber email that’s sent my way. And while the vast majority are generally positive … some aren’t. One of those Negative-Nancy ones was in response to my August 2022 recommendation of Hims & Hers Health Inc. (NYSE: HIMS), the lifestyle health care company I said was a far better “tele-health” play than Teledoc Health Inc. (NYSE: TDOC).
Read More